There was also a difference in the CAR-T cells themselves, and the number of pre-dose CAR-T cells in the CLL responders was limited by the exhausted PD-1+ CD8+ T-cell population. The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.